Evidence map›Paper›PMID 34802048›Full record

ArticleBone marrow transplantation2022

Defining the impact of SARS-COV-2 on delivery of CAR T-cell therapy in Europe: a retrospective survey from the CTIWP of the EBMT.

Sara Ghorashian, Florent Malard, Meltem Kurt Yüksel, Katya Mauff, Jorinde D Hoogenboom, Alvaro Urbano-Ispizua, Jürgen Kuball, Rafael de la Camara, Per Ljungman, Annalisa Ruggeri and 1 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Bone marrow transplantation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Multidimensional Results and Reflections on CAR-T: The Italian Evidence.International journal of environmental research and public health · 2023
    Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sara GhorashianDevelopmental Biology and Cancer, UCL Great Ormond Street Institute of Child Health, London, UK. s.ghorashian@ucl.ac.uk.ORCID http://orcid.org/0000-0002-1555-2946
Florent MalardService d'hématologie clinique et de thérapie cellulaire, Hôpital Saint Antoine, APHP, Sorbonne Université, INSERM UMRs 938, Paris, France.
Meltem Kurt YükselDepartment of Hematology, Ankara University Faculty of Medicine, Ankara, Turkey.
Katya MauffEBMT Statistical Unit, Leiden, The Netherlands.
Jorinde D HoogenboomEBMT Leiden Study Unit, Leiden, The Netherlands.
Alvaro Urbano-IspizuaHospital Clinic Barcelona, Barcelona, Spain.
Jürgen KuballDepartment of Hematology, Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0002-3914-7806
Rafael de la CamaraHospital de la Princesa, Madrid, Spain.ORCID http://orcid.org/0000-0002-8189-5779
Per LjungmanKarolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-8281-3245
Annalisa RuggeriOspedale San Raffaele s.r.l., Haematology and BMT, Milan, Italy.
Christian ChabannonInstitut Paoli-Calmettes, Centre de Lutte Contre le Cancer; Centre d'Investigations Cliniques en Biothérapie, Université d'Aix-Marseille, Inserm CBT 1409, Marseille, France.ORCID http://orcid.org/0000-0002-3755-4889

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Immunotherapy, AdoptiveEuropeHumansRetrospective StudiesSARS-CoV-2

Identifiers

PMID34802048
PMCPMC8605455

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.